Show simple item record

Abstract 5591: Circulating tumor DNA for recurrence prediction and efficacy analysis in the ICONIC trial of peri-operative FLOT and avelumab (PD-L1) in localized esophago-gastric adenocarcinoma

dc.contributor.authorGerlinger, Men_US
dc.contributor.authorGordon, Aen_US
dc.contributor.authorBarber, LJen_US
dc.contributor.authorLaliotis, Gen_US
dc.contributor.authorAthauda, Aen_US
dc.contributor.authorChalloner, Ben_US
dc.contributor.authorWoolston, Aen_US
dc.contributor.authorMansukhani, Sen_US
dc.contributor.authorDunstan, Men_US
dc.contributor.authorPetrou, Nen_US
dc.contributor.authorKhabra, Ken_US
dc.contributor.authorLazaro-Alcausi, Ren_US
dc.contributor.authorCrux, Ren_US
dc.contributor.authorBorja, Ven_US
dc.contributor.authorBegum, Ren_US
dc.contributor.authorRana, Ien_US
dc.contributor.authorPalsuledesai, Cen_US
dc.contributor.authorMalhotra, Men_US
dc.contributor.authorLiu, Men_US
dc.contributor.authorJurdi, Aen_US
dc.contributor.authorSharma, Sen_US
dc.contributor.authorRao, Sen_US
dc.contributor.authorKumar, Sen_US
dc.contributor.authorCunningham, Den_US
dc.contributor.authorChau, Ien_US
dc.contributor.authorStarling, Nen_US
dc.contributor.authorChaudry, MAen_US
dc.date.accessioned2024-07-17T14:05:22Z
dc.date.available2024-07-17T14:05:22Z
dc.date.issued2023-04-04en_US
dc.identifier.issn0008-5472en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/98198
dc.format.extent5591 - 5591en_US
dc.publisherAmerican Association for Cancer Research (AACR)en_US
dc.relation.ispartofCancer Researchen_US
dc.subjectClinical Trials and Supportive Activitiesen_US
dc.subjectPatient Safetyen_US
dc.subjectWomen's Healthen_US
dc.subjectMinority Healthen_US
dc.subjectGeneticsen_US
dc.subjectCanceren_US
dc.subjectHuman Genomeen_US
dc.subjectClinical Researchen_US
dc.subjectHealth Disparitiesen_US
dc.subject6.1 Pharmaceuticalsen_US
dc.subject6 Evaluation of treatments and therapeutic interventionsen_US
dc.subjectCanceren_US
dc.subject3 Good Health and Well Beingen_US
dc.titleAbstract 5591: Circulating tumor DNA for recurrence prediction and efficacy analysis in the ICONIC trial of peri-operative FLOT and avelumab (PD-L1) in localized esophago-gastric adenocarcinomaen_US
dc.typeArticle
dc.identifier.doi10.1158/1538-7445.am2023-5591en_US
pubs.issue7_Supplementen_US
pubs.notesNot knownen_US
pubs.volume83en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record